Registrar confirms share demat processing for Sep 2026 quarter

Compliance View source PDF Explain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹2679.90

prior close

₹2661.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.1%-1.6% vs market

Pharmaceuticals peers, median of 170sector-0.3%-1.2% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.6

15m

-0.7

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+0.1-1.6-0.3-1.2

Next day

-5.3-2.3-2.9-2.7-2.5

-8.3-1.8-6.4-2.7-5.6

-9.4-0.7-8.7-2.6-6.8

-11.6-0.4-11.2-3.0-8.6

-12.7-0.4-12.3-2.9-9.7

-13.9-1.5-12.4-3.4-10.5

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Caplin Point Labs has filed a routine certificate from its Registrar, Integrated Registry Management Services, confirming that shares received for dematerialisation during the quarter ended 30 September 2026 were properly processed. The share certificates were cancelled and the depository's name was added in the company's shareholder register within 15 days, as required under SEBI Depositories Regulations. This is a standard quarterly compliance filing with no business or financial impact.

Likely market impact

Routine regulatory compliance filing. No impact on shareholders or stock price.